---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-002707"
form_type: "8-K"
ticker: "DNTH"
cik: "0001690585"
company_name: "Dianthus Therapeutics, Inc. /DE/"
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:22:59.496691+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dianthus expects ~$173M cash at year-end 2023; to present at JPM conference

## Summary
- Preliminary unaudited cash, equivalents, and short-term investments of ~$173M as of Dec 31, 2023.
- Audited FY2023 financials not yet available; actual results may differ materially.
- CEO Marino Garcia to present at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024.

## SEC filing metadata
- accession: 0000950170-24-002707
- form_type: 8-K
- ticker: DNTH
- cik: 0001690585
- company_name: Dianthus Therapeutics, Inc. /DE/
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690585/000095017024002707/0000950170-24-002707-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690585/000095017024002707/dnth-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-002707
- JSON: https://secwatch.observer/filing/0000950170-24-002707.json
- Plain text: https://secwatch.observer/filing/0000950170-24-002707.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.